Financhill
Sell
11

CDT Quote, Financials, Valuation and Earnings

Last price:
$2.21
Seasonality move :
-51.38%
Day range:
$2.13 - $2.27
52-week range:
$2.13 - $622.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.65x
Volume:
149.1K
Avg. volume:
589.6K
1-year change:
-99.42%
Market cap:
$1.7M
Revenue:
--
EPS (TTM):
-$237.75

Earnings Data

Next earnings date for CDT
Aug 12
2025
Most recent earnings per share
-$19.80
Missed by $19.80
(May 15/2025)
Consensus Estimate
--
(May 15/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CDT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/15/2025 Q1 -- -- -$19.80 -- --
12/31/2024 Q4 -- -- -$7.95 -- --
11/14/2024 Q3 -- -- -$105.00 -- --
08/12/2024 Q2 -- -- -$105.00 -- --
05/14/2024 Q1 -- -- -$72.15 -- --
12/31/2023 Q4 -- -- -$43.80 -- --
11/20/2023 Q3 -- -- $15.00 -- --
06/30/2023 Q2 -- -- -$35.90 -- --
03/31/2023 Q1 -- -- -$34.63 -- --
12/31/2022 Q4 -- -- -$63.61 -- --
09/30/2022 Q3 -- -- -$19.80 -- --
03/31/2022 Q1 -- -- -$6.36 -- --

Conduit Pharmaceuticals Earnings Questions

  • How Much did Conduit Pharmaceuticals Generate in Revenue Last Quarter?

    Conduit Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did Conduit Pharmaceuticals Beat Earnings Last Quarter?

    Conduit Pharmaceuticals announced earnings per share of -$19.80 which represents a miss of analyst forecast a -- per share.

  • Is Conduit Pharmaceuticals Profitable?

    Conduit Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Conduit Pharmaceuticals EPS Next Year?

    Conduit Pharmaceuticals's earnings are forecast to grow from -$307.95 per share to -- per share next year representing an increase of --.

  • When is Conduit Pharmaceuticals's Earnings Date?

    Conduit Pharmaceuticals's next earnings date is August 12, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Can Levi Stock Double?
Can Levi Stock Double?

Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…

Stock Ideas

Buy
70
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 58x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
82
SBET alert for Jul 17

SharpLink Gaming [SBET] is down 2.6% over the past day.

Buy
89
EXOD alert for Jul 17

Exodus Movement [EXOD] is down 4.14% over the past day.

Buy
60
U alert for Jul 17

Unity Software [U] is up 7.51% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock